Reversal of liver fibrosis
Authors:
Open Access
- 1 January 2009
- journal article
- new horizon
- Published by Wolters Kluwer Health in Saudi Journal of Gastroenterology
- Vol. 15 (1) , 72-9
Abstract
Hepatic fibrosis is a scarring process associated with an increased and altered deposition of extracellular matrix in the liver. It is caused by a variety of stimuli and if fibrosis continues unopposed, it would progress to cirrhosis which poses a significant health problem worldwide. At the cellular and molecular level, this progressive process is characterized by cellular activation of hepatic stellate cells and aberrant activity of transforming growth factor-β with its downstream cellular mediators. Liver biopsy has been the reference test for assessment of hepatic fibrosis, but because of its limitations, noninvasive markers of liver fibrosis were developed. Liver fibrosis or cirrhosis was considered irreversible in the past but progress of research on the molecular pathogenesis of liver fibrosis has shown that hepatic cellular recovery is possible. Currently, no acceptable therapeutic strategies exist, other than removal of the fibrogenic stimulus, to treat this potentially devastating disease.Keywords
This publication has 94 references indexed in Scilit:
- The role of adipokines in liver fibrosisPathophysiology, 2008
- Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis CHepatology, 2008
- Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patientsHepatology, 2007
- Progression of fibrosis in advanced chronic hepatitis CHepatology, 2007
- Performance of serum marker panels for liver fibrosis in chronic hepatitis CJournal of Hepatology, 2006
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CHepatology, 2004
- Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patientsJournal of Hepatology, 2004
- Cirrhosis reversal: a duel between dogma and mythJournal of Hepatology, 2004
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003
- Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis BJournal of Hepatology, 2001